Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2004 1
2010 1
2011 1
2012 3
2013 1
2014 5
2017 3
2018 3
2019 2
2020 2
2021 2
2022 3
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber RD, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, McFadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr; OlympiA Clinical Trial Steering Committee and Investigators. Tutt ANJ, et al. N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3. N Engl J Med. 2021. PMID: 34081848 Free PMC article. Clinical Trial.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Explainable time-to-progression predictions in multiple sclerosis.
D'hondt R, Dedja K, Aerts S, Van Wijmeersch B, Kalincik T, Reddel S, Havrdova EK, Lugaresi A, Weinstock-Guttman B, Mrabet S, Lalive P, Kermode AG, Ozakbas S, Patti F, Prat A, Tomassini V, Roos I, Alroughani R, Gerlach O, Khoury SJ, van Pesch V, Sá MJ, Prevost J, Spitaleri D, McCombe P, Solaro C, van der Walt A, Butzkueven H, Laureys G, Sánchez-Menoyo JL, de Gans K, Al-Asmi A, Deri N, Csepany T, Al-Harbi T, Carroll WM, Rozsa C, Singhal B, Hardy TA, Ramanathan S, Peeters L, Vens C; MSBase Study Group. D'hondt R, et al. Comput Methods Programs Biomed. 2025 May;263:108624. doi: 10.1016/j.cmpb.2025.108624. Epub 2025 Feb 6. Comput Methods Programs Biomed. 2025. PMID: 39965473
Comparison between the EKFC-equation and machine learning models to predict Glomerular Filtration Rate.
Nakano FK, Åkesson A, de Boer J, Dedja K, D'hondt R, Haredasht FN, Björk J, Courbebaisse M, Couzi L, Ebert N, Eriksen BO, Dalton RN, Derain-Dubourg L, Gaillard F, Garrouste C, Grubb A, Jacquemont L, Hansson M, Kamar N, Legendre C, Littmann K, Mariat C, Melsom T, Rostaing L, Rule AD, Schaeffner E, Sundin PO, Bökenkamp A, Berg U, Åsling-Monemi K, Selistre L, Larsson A, Nyman U, Lanot A, Pottel H, Delanaye P, Vens C. Nakano FK, et al. Among authors: d hondt r. Sci Rep. 2024 Nov 2;14(1):26383. doi: 10.1038/s41598-024-77618-w. Sci Rep. 2024. PMID: 39487227 Free PMC article.
Identifying transferable lessons from cholera epidemic responses by Médecins Sans Frontières in Mozambique, Malawi and the Democratic Republic of Congo, 2015-2018: a scoping review.
D'Mello-Guyett L, Cumming O, Rogers E, D'hondt R, Mengitsu E, Mashako M, Van den Bergh R, Welo PO, Maes P, Checchi F. D'Mello-Guyett L, et al. Among authors: d hondt r. Confl Health. 2022 Mar 29;16(1):12. doi: 10.1186/s13031-022-00445-1. Confl Health. 2022. PMID: 35351171 Free PMC article.
Malnutrition prevalence in cancer patients in Belgium: The ONCOCARE study.
Rasschaert M, Vandecandelaere P, Marechal S, D'hondt R, Vulsteke C, Mailleux M, De Roock W, Van Erps J, Himpe U, De Man M, Mertens G, Ysebaert D. Rasschaert M, et al. Among authors: d hondt r. Support Care Cancer. 2024 Jan 27;32(2):135. doi: 10.1007/s00520-024-08324-6. Support Care Cancer. 2024. PMID: 38280135 Free PMC article.
Long-lasting insecticidal nets provide protection against malaria for only a single year in Burundi, an African highland setting with marked malaria seasonality.
Van Bortel W, Mariën J, Jacobs BKM, Sinzinkayo D, Sinarinzi P, Lampaert E, D'hondt R, Mafuko JM, De Weggheleire A, Vogt F, Alexander N, Wint W, Maes P, Vanlerberghe V, Leclair C. Van Bortel W, et al. Among authors: d hondt r. BMJ Glob Health. 2022 Dec;7(12):e009674. doi: 10.1136/bmjgh-2022-009674. BMJ Glob Health. 2022. PMID: 36455989 Free PMC article.
Typhoid fever outbreak in the Democratic Republic of Congo: Case control and ecological study.
Brainard J, D'hondt R, Ali E, Van den Bergh R, De Weggheleire A, Baudot Y, Patigny F, Lambert V, Zachariah R, Maes P, Kuma-Kuma Kenge D, Hunter PR. Brainard J, et al. Among authors: d hondt r. PLoS Negl Trop Dis. 2018 Oct 3;12(10):e0006795. doi: 10.1371/journal.pntd.0006795. eCollection 2018 Oct. PLoS Negl Trop Dis. 2018. PMID: 30281598 Free PMC article.
30 results